NCT01129557 - Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

January 31, 2012

Study Completion Date

December 31, 2012

Conditions

Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive NephrosclerosisIgA NephropathyFocal Segmental GlomerulosclerosisGlomerulopathy (Obesity-associated)Glomerulonephritis, Membranous

Interventions

DRUG

Aliskiren

DRUG

Valsartan

Trial Locations (1)

10032

Columbia University Medical Center, New York